Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A condition characterized by infiltration of the lung with eosinophils due to inflammation or other disease processes. Major eosinophilic lung diseases are the eosinophilic pneumonias caused by infections, allergens, or toxic agents.
Biomarker and diagnostic research for pulmonary eosinophilia has been reported in the published literature.
2 clinical trials registered. Interventions under study include other interventions and biologic therapy. Pipeline includes 1 PHASE4. Research is primarily sponsored by academic and government institutions.
98 publications have been identified in PubMed for pulmonary eosinophilia. Research spans Case Report / Case Series (31%), Review / Meta-Analysis (22%), and Epidemiology / Natural History (13%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 30 |
Data assembled from 3 of 12 sources · Last updated Oct 3, 2026, 8:11 PM UTC
Research summaries | 21 | 22% |
Disease patterns and progression | 13 | 13% |
Laboratory research | 11 | 11% |
Testing and diagnosis research | 10 | 10% |
Clinical study results | 7 | 7% |
Other research | 3 | 3% |
New treatment approaches | 2 | 2% |
Salahuddin M (2026). [PMID: 29261977](https://pubmed.ncbi.nlm.nih.gov/29261977/). *Unknown Journal*. [Review / Meta-Analysis]
Dupont L (2026). [PMID: 42044815](https://pubmed.ncbi.nlm.nih.gov/42044815/). *Respir Med*. [Epidemiology / Natural History]
Meara EM (2026). [PMID: 40833804](https://pubmed.ncbi.nlm.nih.gov/40833804/). *Pediatr Dermatol*. [Case Report / Case Series]
Emmi G (2026). [PMID: 41786383](https://pubmed.ncbi.nlm.nih.gov/41786383/). *J Allergy Clin Immunol Pract*. [Review / Meta-Analysis]
Šarc I (2026). [PMID: 41685694](https://pubmed.ncbi.nlm.nih.gov/41685694/). *Ther Adv Respir Dis*. [Epidemiology / Natural History]
Jha SK (2026). [PMID: 32491456](https://pubmed.ncbi.nlm.nih.gov/32491456/). *Unknown Journal*. [Epidemiology / Natural History]
Matera MG (2026). [PMID: 41412959](https://pubmed.ncbi.nlm.nih.gov/41412959/). *Expert Rev Respir Med*. [Review / Meta-Analysis]
Hu J (2026). [PMID: 42100248](https://pubmed.ncbi.nlm.nih.gov/42100248/). *Front Med (Lausanne)*. [Epidemiology / Natural History]
Pérez de Llano L (2026). [PMID: 41786384](https://pubmed.ncbi.nlm.nih.gov/41786384/). *J Allergy Clin Immunol Pract*. [Review / Meta-Analysis]
Muthu V (2026). [PMID: 41654182](https://pubmed.ncbi.nlm.nih.gov/41654182/). *J Allergy Clin Immunol Pract*. [Case Report / Case Series]